Article,

Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data.

, , , , , and .
(xx Jul 2006)10.1053/j.ajkd.2006.04.077.

Abstract

SR of RCT -- The combination of ACE-inhibitor and ARB therapy in patients with chronic proteinuric renal disease is safe, without clinically meaningful changes in serum potassium levels or glomerular filtration rates

Tags

Users

  • @abelmora

Comments and Reviews